CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
An analysis of volatility between Total Market and SP 500 funds in retirement contexts, addressing risk tolerance and safeguard strategies.
28,209 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Figure Technology Solutions agrees to purchase Kiavi for $717 million, expanding first-lien volume by about 40% and b...
A small board-game importer plans to manufacture Monopoly in the United States after tariffs push production home, a ...
NVIDIA backs LUMENTUM and COHERENT with a $4B stake to accelerate AI data movement; analysts weigh the upside and ris...
Elon Musk is stirring the pot once again with Terafab, the newest idea from elon that aims to redefine manufacturing ...
A fast-growing Brazilian fintech is reshaping personal finance in Latin America. Here are three concrete reasons this...
As crypto markets wobble, financial advisors managing $175 trillion are widening their focus beyond Bitcoin to stable...
A billionaire places a bold personal bet on a private space company. This article breaks down what that move means fo...
As rates cool, Angel Oak’s Hutchens charts a growth path for non-QM lending with a sharper focus on product expansion...
Five insiders each owning at least 10% recently sold shares of V2X, Inc., totaling 2.55 million shares for about $173...
A federal judge granted preliminary approval to a group of tuccori opt-in settlements preliminary totaling $106 milli...
Mexico’s president calls for FIFA to reconsider 2026 World Cup ticket prices amid affordability concerns as families ...